Completed
PAXIL CR Bioequivalence Study
NCT00749359
- Conditions
- Depressive Disorder, Mental Disorders, Mood Disorders
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
- GSK Investigational Site Tacoma, Washington, United States